SPERO THERAPEUTICS INC
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About SPRO
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant (MDR) bacterial infections with unmet need. Its product candidate SPR720 is an investigational, chemically stable phosphate ester prodrug that is converted in vivo to SPR719 for the treatment of nontuberculous mycobacterial (NTM) pulmonary disease. Its clinical stage product candidate, tebipenem HBr is an investigational oral carbapenem antibiotic being developed for the treatment of complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP) to help patients potentially reduce duration of in-patient therapy.
Find out what a historical investment in SPERO THERAPEUTICS INC would be worth today using our SPRO stock calculator.
$161.58M
-
0.00%
32.82K
$3.06
$2.71
$0.00
$3.06
$0.51
Ready to start your investing journey with Stake?
Open an accountSPRO FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SPRO
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SPRO
on Stake
Buy SPRO from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of SPRO from only US$10 with fractional shares
